This site looks better in landscape mode

A new drug for osteoarthritis and other diseases of ageing

A new drug for osteoarthritis and other diseases of ageing

Over 50%

Over half of people diagnosed with knee osteoarthritis are under 65 years of age

NEWS

ACR Convergence 2026 Abstract

Read More

NEWS

The first p2b abstract is hot off the press

Read More

NEWS

P2b Dose Ranging Study

Read More

NEWS

 

ACR Convergence 2026 Abstract

Read More

 

The first p2b abstract is hot off the press

Read More

 

P2b Dose Ranging Study

Read More